07 Jan 2001

MCP Hexal® (MCP Hexal® 10 Tabletten) - Deutschland

Updated: 07 Jan 2001

MCP Hexal® 10; -Tropfen; -injekt

Motilitätsstör. des oberen Magen-Darmtraktes. Übelkeit u. Erbrechen, Brechreiz. Zusätzlich bei Inj.-lsg.: z. Erleichterung der Duodenal- u. Jejunalsondierung. Beschleunigung der Magenentleerung und Dünndarmpassage bei d. röntgenologischen Untersuchung.

MCP Hexal® Description, Presentation and Dosage

MCP Hexal® Description

MCP Hexal® Drug Class Description

Einzelstoffe

MCP Hexal® Drug Description

1 Tbl. enth.: Metoclopramid-HCl 1H2O 10,53 mg (entspr. 10 mg Metoclopramid-HCl).

MCP Hexal® Generic Name

MCP Hexal® 10 Tabletten

MCP Hexal® Presentation

MCP Hexal® Presentation

MCP Hexal® 10; -Tropfen; -injekt

MCP Hexal® Manufacturer

Hexal

Related Learning Zones

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

G.MKT.GM.MH.01.2016.0364

Obesity CME series

Obesity CME series

This European Obesity Initiative CME series contains three online modules, which are ideal for healthcare professionals looking to widen their understanding of obesity as a serious medical illness. Each module is EACCME-accredited and free to complete. Successful completion of the series will earn participants a combined total of 5 European CME credits (ECMECs).

MCP Hexal® Dosage

MCP Hexal® Adult Dosage

Calciumhydrogenphosphat, Lactose, Magnesiumstearat, Poly(O-carboxymethyl)stärke-Natrium, Maisstärke, Siliciumdioxid. ger. Wasser.

MCP Hexal® Child Dosage


MCP Hexal® Tropfen
Zus.: 1 ml (ca. 15 Tr.) enth.: Metoclopramid-HCl 1H2O 4,21 mg (entspr. 3,56 mg Metoclopramid bzw. 4 mg Metoclopramid-HCl).
Weit. Bestandteile: Methyl-4-hydroxybenzoat 1,3 mg, Propyl-4-hydroxybenzoat 0,2 mg, Natriumcyclamat, Natriumdihydrogenphosphat, Natriummetabisulfit, Saccharin-Natrium,

MCP Hexal® injekt Injektionslösung
Zus.: 1 Amp. (2 ml) enth.: Metoclopramid-HCl 1H2O 10,53 mg (entspr. 10 mg Metoclopramid-HCl).
Weit. Bestandteile: Natriumchlorid, Wasser f. Inj.-zwecke.

MCP Hexal® Precautions, Reactions and Contraindications

MCP Hexal® Special Precautions

MCP Hexal® Special Precautions

D 70 a-f, Z 3. Säugl. u. Kleinkdr. bis 2 J.

MCP Hexal® Adverse Reactions

MCP Hexal® Adverse Reactions

D 70

Related Drugs - Gastroenterology

Back to top